Clinica chimica acta; international journal of clinical chemistry, vol.412, pp.134-8, 2011 (SCI-Expanded)
Background: Quantification of nitisinone, 2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione (NTBC) has been repeatedly described. Nevertheless monitoring of NTBC has not yet become part of routine therapy surveillance in tyrosinaemia type I (OMIM 276700).